Physician profile
Jonathan J Levin
NPI 1144409137
$1,963.68
in general payments reported to CMS, 2019-2025
16 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $195 · 2021: $287 · 2022: $466 · 2023: $404 · 2024: $136 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.53 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $314.36 | 2022-2025 | |
| Rxsight INC | $295.98 | 2020-2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Allergan, INC. | $243.48 | 2019-2022 | |
| Alcon Vision LLC | $183.94 | 2019-2025 | Hydrus Microstent, Eysuvis, Tryptyr |
| Glaukos Corporation | $143.77 | 2021-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Stryker Corporation | $133.36 | 2020 | |
| Bausch & Lomb Americas INC. | $122.82 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Johnson & Johnson Surgical Vision, INC. | $114.06 | 2019-2024 | Tecnis Simplicity |
| Carl Zeiss Meditec USA, INC. | $105.69 | 2022 | |
| Beaver-Visitec International, INC. | $104.04 | 2025 | |
| Dompe US, INC. | $71.68 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.06 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $33.87 | 2022 | |
| Amgen INC. | $22.05 | 2025 | Tepezza |
| Haemonetics Corporation | $21.03 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $14.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.